Business
Envoy Medical to Participate in the 37th Annual ROTH Conference
White Bear Lake, Minnesota--(Newsfile Corp. - March 10, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices, today announced that it will participate in the 37th Annual ROTH Conference being held on March 16 - 18, 2025 at the Laguna Cliffs Marriott Resort and Spa in Dana Point, California.Brent Lucas, Chief Executive Officer, and David R. Wells, Chief Financial Officer, will be holding ...
About this update from Envoy Medical, Inc.
[{"type":"text","content":"White Bear Lake, Minnesota--(Newsfile Corp. - March 10, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices, today announced that it will participate in the 37th Annual ROTH Conference being held on March 16 - 18, 2025 at the Laguna Cliffs Marriott Resort and Spa in Dana Point, California.","length":393,"tagName":"p"},{"type":"text","content":"Brent Lucas, Chief Executive Officer, and David R. Wells, Chief Financial Officer, will be holding one-on-one meetings with investors and analysts at the conference to discuss recent events and provide an update.","length":212,"tagName":"p"},{"type":"text","content":"Registered attendees of the conference are encouraged to request a one-on-one meeting by contacting a ROTH representative or through the conference's on-line platform.","length":171,"tagName":"p"},{"type":"text","content":"About the Fully Implanted Acclaim® Cochlear Implant","length":51,"tagName":"p"},{"type":"text","content":"We believe the fully implanted Acclaim Cochlear Implant ("Acclaim CI") is a first-of-its-kind hearing device. Envoy Medical's fully implanted technology includes a sensor designed to leverage the natural anatomy of the ear instead of a microphone to capture sound.","length":278,"tagName":"p"},{"type":"text","content":"The Acclaim CI is designed to address severe to profound sensorineural hearing loss that is not adequately addressed by hearing aids. The Acclaim CI is expected to be indicated for adults who have been deemed adequate candidates by a qualified physician.","length":254,"tagName":"p"},{"type":"text","content":"The Acclaim Cochlear Implant received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) in 2019.","length":131,"tagName":"p"},{"type":"text","content":"CAUTION The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by Federal (or United States) law to investigational use.","length":148,"tagName":"p"},{"type":"text","content":"About the Esteem® Fully Implanted Active Middle Ear Implant (FI-AMEI)","length":69,"tagName":"p"},{"type":"text","content":"The Esteem fully implanted active middle ear implant (FI-AMEI) is the only FDA-approved, fully implanted* hearing device for adults diagnosed with moderate to se...